Specialized Pharmaceutical Services
Specialized pharmaceutical services beyond a CRO support the convergence of new technology and pharmaceutical innovation.
North American Biocompatibility Summit (NABS) 2024
September 11, 2024
Eurofins EAG Laboratories is proud to be the presenting sponsor for the North American Biocompatibility Summit (NABS) at Quincy Hall in Minneapolis, Minnesota.
Dr. Philip Ferko, Senior Scientist and Team Leader for EAG Laboratories, will present “Examine Contemporary Challenges to Identification and Confidence Level Assignment and Approaches to Overcoming Them.”
In addition, Dr. Steven R. Doonan, Manager for EAG Laboratories will co-present “Surface Chemistry Considerations When Evaluating Biocompatibility of Release Product Management” with Drs. Chad Satori and Catherine Christensen from Medtronic.
Visit the link below to see the NABS schedule or contact us to learn more about medical device testing solutions.
We hope to see you there!
More content you might like...
Characterization of Trace Impurities in 3D-Printed Recycled ABS Materials
Recycled ABS Materials show numerous deleterious effects on molecular integrity of plastic materials, as seen in FTIR, XRF and GPC
Types of crystal defects that can be observed with TEM
Transmission Electron Microscopy is often used to evaluate defects in crystals, but not all defects can be observed with TEM
Impurity depth direction analysis of various glass materials by SIMS
SIMS analysis is used to measure trace impurities in various materials such as semiconductors, metal, and insulating materials
Generic Pharmaceuticals Brochure
How do you leverage the power of materials science to get generic drugs to market smart, faster and with less risk?
ICP-OES and ICP-MS Detection Limit Guidance
ICP-OES and ICP-MS detection limit guidance from EAG Laboratories is based on the strengths and limitations of these valuable techniques.